The Medicine profession is considered technical. Neurologists such as Dr. Shiva Gopal Vasishita, for instance, are specifically trained in the diagnosis and treatment of nervous system disorders including ailments of the brain, spinal cord, nerves, and muscles. They are subjected to a rigorous education system meant to build their capacity of the complexities that await them in neurology.
Dr.Shiva Gopal Vasishita happens to be one of the practicing neurologists we have today. He graduated from Government Medical College in 1979 and has been practicing both neurology and psychiatry for 40years now in Voorhees, New Jersey. Dr. Shiva is affiliated with Kennedy Health System Cherry Hill Campus. In his line of work, Dr. Shiva plays a vital role in explaining the mechanisms of a traumatic brain injury, the results of clinical examination and the significance of diagnostic test results.
On 1st February 2017, the National Institute of Health disclosed that evidence from recent trials suggested that high-dose immunosuppressive therapy then a transplant of a person’s blood- forming stem cells had the ability to induce sustained remission of relapsing-remitting multiple sclerosis. This is an autoimmune disease in which a person’s immune system attacks the central nervous system. 69 percent of the trial participants survived without experiencing progression of disability, relapsing of MS syndrome or new brain lesions five years later after receiving high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT). The participants did not need any MS medication after receiving HDIT/HCT.
The trial that was sponsored by the National Institute of Allergy and Infectious Diseases (NIAD) published the final five-year results in Neurology- the medical journal of the American Academy of Neurology on 1st February.
The possibility of a one-time HDIT/HCT treatment being substantially more effective than long-term treatment with medications for Multiple Sclerosis is great news for neurologists such as Dr. Shiva who are committed to getting breakthroughs in solving brain diseases.